LENZ LENZ Therapeutics, Inc.

$4.52▼ -4.24% Healthcare Other
After hours $4.53▲ +0.22% Sep 11, 7:30 PM ET
Volume 972.6K Avg Volume (10D) 666.7K
Key Metrics & Fundamentals
Market Cap
$142.02M
P/E Ratio
–
Div Yield
–%
52W Range
4.50 - 50.40
% vs 50 MA
-13.27%
% vs 200 MA
-59.09%
RSI-14
38.6
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.46
Free Cash Flow
-$38.73M
Gross Rev
$5.49M
Gross Profit
$5.21M
EBITDA
-$34.06M
COGS
$280,000
Operating Exp
$39.38M
Operating Income
-$34.17M
EBIT
-$34.17M
Pretax Income
-$31.92M
Net Income
-$31.92M
EPS (Diluted)
-1.02
Price & Volume History
Loading chart…
Recent News
LENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 1:55 PM
LENZ Therapeutics (LENZ) Stock Sees Fair Value Moves Lower After Analyst Target Cuts
Simply Wall St. · Aug 15, 2026 1:12 AM
LENZ Therapeutics Inc (LENZ) (Q2 2026) Earnings Call Highlights: VIZZ Launch Momentum ...
GuruFocus.com · Aug 12, 2026 5:02 AM
LENZ Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 2:39 AM
LENZ Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 11, 2026 11:04 PM
LENZ Therapeutics, Inc. (LENZ) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 11, 2026 9:25 PM
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · Aug 11, 2026 8:05 PM
LENZ Therapeutics Inc (LENZ) Q2 2026 Earnings Report Preview: What To Look For
GuruFocus.com · Aug 10, 2026 1:23 PM
CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 6, 2026 1:50 PM
LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
GlobeNewswire · Aug 4, 2026 8:05 PM
Financial Overview - Income Statement Quarterly

See LENZ's money flow as a full page

Social Sentiment
Avg +0.10 · 12 posts
DDDiscussionLENZ - May help us get a Benz. 54% Shrt Float.
r/wallstreetbets · Jun 28, 2026
Referencing a high short float is generally considered bullish sentiment for a stock.
positive +0.30
EarningsDiscussionStock prices seem to be consistently dropping after earnings calls (even on positive news). Do you think this will hold for ONDS tomorrow?
r/investing · Mar 24, 2026
LENZ is experiencing a significant drop due to high launch expenses.
negative -0.70
NewsDD$LENZ Therapeutics vision enhancing eye drops being well received in first month of distribution post FDA approval.
r/wallstreetbets · Oct 27, 2025
The post describes positive reception and FDA approval, indicating favorable sentiment.
positive +0.80
NewsDD$LENZ Therapeutics eye sight improving drops continue to impress. Major concern was public reception of the drug.
r/wallstreetbets · Oct 27, 2025
The post highlights positive user feedback and continued success following FDA approval, indicating a bullish sentiment.
positive +0.80
DDNewsDiscussionYahoo Finance / Simply Wall Street article on if $LENZ Therapeutics has enough cash runway for their expansion into the market staring in Q4
r/wallstreetbets · Oct 2, 2025
The post highlights poor adoption rates, break-even concerns, and potential rejection risks, indicating a negative outlook for the stock.
negative -0.70
Page 1 of 3 (12 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙